A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplanation

This pilot study evaluates the degree of side effects during high-dose chemotherapy (HD-VIC) plus autologous bone marrow transplant (HDCT) and its possible prevention by the cytoprotective thiol-derivate amifostine. Additionally, the in-patient medical costs of both treatment arms were compared. 40...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hartmann, J T, Vangerow, A von, Fels, L M, Knop, S, Stolte, H, Kanz, L, Bokemeyer, C
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2001
Teme:
Regular Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363753/
https://ncbi.nlm.nih.gov/pubmed/11161394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1611
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items